A study to assess efficacy of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome
Phase of Trial: Phase II
Latest Information Update: 10 May 2016
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Frozen shoulder
- Focus Therapeutic Use
- Sponsors Auxilium Pharmaceuticals
- 10 May 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jul 2016, as per BioSpecifics Technologies media release.
- 09 Nov 2015 According to a Biospecifics Technologies media release, the company confirms that this study will initiate shortly.
- 12 May 2015 New trial record